Related Experiment Videos
Cognitive decline after invasive intervention in cardiovascular disease: is it drug related?
Diane Nykamp1, Joshua Morgan, Amanda Roland
1Mercer University College of Pharmacy and Health Sciences, Atlanta, Georgia 30341, USA. Nykamp_D@Mercer.edu
Objective:
To identify drugs used to treat cardiovascular disease (CVD) after an invasive intervention that may adversely affect cognitive function.
Setting:
Ambulatory care setting.
Practice Description:
A pharmacy faculty member serves as an ambulatory care preceptor for students at a cardiac rehabilitation and wellness center on the campus of St. Joseph's Hospital, Atlanta, Georgia. Pharmacy services include patient case reviews, consultations, patient education, and therapeutic recommendations.
Practice Innovation:
As part of the advanced practice experience, students are responsible for monitoring drug therapy regimens and conducting medication reconciliations. A literature review of primary sources and education databases was conducted to report cognitive adverse drug reactions associated with cardiac drugs in selective electronic tertiary sources.
Main Outcomes:
Documentation of cognitive dysfunction associated with drugs used to treat CVD.
Results:
Drugs used to treat CVD may be associated with adverse drug effects including short-term memory loss, amnesia, confusion, decreased mental acuity, and impaired concentration.
Conclusion:
Pharmacists providing consultation in the cardiac rehabilitation setting can provide insight into medications that can contribute to cognitive dysfunction.
Related Concept Videos
Dementia l: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer Disease l: Introduction
Peripheral Artery Disease III: Interprofessional Care